China Chamber of Commerce for Import and Export of Medicines and Health Products released a new edition of “the International Business Standards for Plant Extracts”. The release of this standard is conducive to regulating the export of plant extracts in China and improving international competitiven
Plant extracts is the main force of China's exports of Chinese goods, exports accounted for the total exports of Chinese medicine products accounted for more than 40%. Although the plant extract industry is an emerging industry, but over the past decade of rapid development. From the Health Insurance Association data show that in 2002, China's exports of plant extracts export only $ 190 million in 2011 annual compound growth rate of 21.91%. Not only that, the plant extracts in recent years, exports more showing a trend of volume and price increases, especially the average export prices rose significantly. In 2015, the plant extracts exports reached $1.13 billion, a year-on-year increase of 47%,
The first major exporter of Chinese plant extracts is the United States accounting for exports of 30.06%. The 21.82% are exported to Europe, 16.86% are exported to Japan. Plant extracts advantage of China's vast plant resources and relatively low operating costs. Increase of the overall trend of global aging and the natural demand for drugs will continue to provide a huge market space, which provides development opportunities for China's plant extracts. Plant extracts come from agricultural products, development of the industry will be able to drive a new type of rural development.
With the fast development of the plant extract industry, China is one of the major suppliers of plant extracts in the world, thanks to its advantages of abundant resources and traditional medicine culture. In the domestic plant extract industry, ginkgo balboa extract, green tea extract, ginseng extract, liquorice extract and honeysuckle extract are highlighted.